TheStreetPro TSP Site

My take today $MSOS The recent downward slide in the cannabis sector into the close is a classic manifestation of a highly engineered structural volatility trap, rather than an insider information leak. @V_arrell (just my take but I want to stay positive) Because institutional… https://t.co/DF1geVQOoJ

— Nina Rosella Strange (@RosellaStrang) October 13, 2026

Position: None

After an extended oversold period, the S&P Short Range Oscillator finally moved into overbought (at 0.06%).

Position: None 

Position: None

Closing Volume

– NYSE volume 9% below its one-month average 

– NASDAQ volume 16% below its one-month average 

– VIX index: up 0.39% to 15.27

Breadth

S&P 500 Sectors

% Movers

Heat Maps

Position: None

The Dales Report with Shadd and Anthony discusses the rescheduling issue today.

“Trade to Black” is by far the best real-time source of all things cannabis.

The podcast started at 4 PM.

Let’s go to the tape.

Ex-DEA Agent Speaks Out on Chinese Illicit Grows https://t.co/XjKDVwAG4u

— TDR (@TheDalesReport) October 13, 2026

Position: None

Today’s deadline is a filing deadline, not a decision point. October 13 is a filing deadline, not a scheduled restart or decision date. Chief ALJ Derek Julius set no deadline for a ruling on the motion or for a recommended decision. I couldn’t find reporting yet on what was actually filed today, so what follows is my read of the likely paths. mgmagazinemugglehead

What’s being decided: The order directs the government and other participants to respond to a motion seeking to introduce the newly released GAO report into the administrative record. The government’s response may run up to 20 pages. Other designated participants may respond under the same specifications but aren’t required to. gmlawkindgreenbuds

Likely outcomes after the filings

1. The judge denies the motion and lifts the stay. This is the path the industry commentary seems to expect. The GAO report predates these rescheduling proceedings, does not target cannabis explicitly, and did not conclude that the agencies violated the law or reject the scientific findings supporting Schedule III placement. The judge would then resume work on his non-binding recommendation to the DEA Administrator. gmlaw
2. The judge admits the report but doesn’t allow more briefing. The report goes into the record and the case resumes, with the report’s weight left for later stages.
3. The judge admits the report and allows supplemental briefing. This is what the movants want. It would delay his recommendation further, since the proceeding stays paused while the parties file additional briefs.
4. The judge reopens the record more broadly. This is the least likely and most disruptive path. The movants argue that the proper course is a new evaluation under a written standard, not a final rule on this record. The judge could decide the GAO findings justify more than a short supplement, though nothing so far suggests he’s leaning that way. ndasa

What the government is likely to argue: The GAO report found that for all 84 substances with final rules requiring a federal health recommendation, DEA’s decisions aligned with the recommendation. The agencies also concurred with GAO’s recommendations for written policies and an updated FDA–NIH agreement. That gives them room to argue the report is procedural, not substantive, and doesn’t undermine the Schedule III findings. I can’t confirm that’s the position they took in their filing. muggleheadkindgreenbuds

What doesn’t change: Whatever happens, April’s separate medical-cannabis order is unaffected. Even after the judge resumes, his recommendation is only a step toward agency action, rather than the final rule itself. The DEA Administrator still has to act. mgmagazinekindgreenbuds

Position: None